Pentair reports reduced production in facilities due to Covid-19 restrictions, indicating significant operational disruptions.
Pentair plc says it has experienced reduced production in a number of key facilities as the result of “shelter in place” orders and suspensions of operations in several facilities due to the Covid-19 pandemic.
No takes yet. Share an insight, caveat, or question.
A 2020 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: